エーザイ：EISAI INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BLA OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY - 有報キャッチャー

エーザイ（4523）　EISAI INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BLA OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY 2021/09/28

/-

読み込み中…